Drug application
ENOXAPARIN SODIUM (ENOXAPARIN SODIUM)
Drugs@FDA ANDA 208600 · AMPHASTAR PHARMS INC
Key facts
| Drug name | ENOXAPARIN SODIUM |
|---|---|
| Active ingredients | ENOXAPARIN SODIUM |
| Application type | ANDA |
| Application number | 208600 |
| Company | AMPHASTAR PHARMS INC |
| Dosage forms | INJECTABLE, INTRAVENOUS, SUBCUTANEOUS |
| Strength | 300MG/3ML (100MG/ML) |
| Marketing status | Prescription |
| TE codes | AB |
| Reference listed drug | No |
| Latest submission status date | Mar 14, 2019 |
At a glance
- 1–9 Submissions
- 1–9 Supplements
- None Label versions
- 1–9 Products
- 1–9 Therapeutic equivalents
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA applications
Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.